Vascular endothelial activation, resulting from the high levels of inflammatory cytokines (IL6, TNFγ and TNFβ), has been suggested to contribute to the development of CRS and ICANS after CAR-T therapy. This evidence concerns the gene LTA and congenital rubella syndrome.